REVANCE THERAPEUTICS Trademark

Trademark Overview

On Tuesday, August 3, 2021, a trademark application was filed for REVANCE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the REVANCE THERAPEUTICS trademark a serial number of 90862492. The federal status of this trademark filing is REGISTERED as of Tuesday, May 27, 2025. This trademark is owned by Revance Therapeutics, Inc.. The REVANCE THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain
revance therapeutics

General Information

Serial Number90862492
Word MarkREVANCE THERAPEUTICS
Filing DateTuesday, August 3, 2021
Status700 - REGISTERED
Status DateTuesday, May 27, 2025
Registration Number7811732
Registration DateTuesday, May 27, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain; pharmaceutical preparations, namely, peptide substrates for use in the treatment of neurological disorders, muscle dystonias, muscle spasms, and pain
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 28, 2021
Primary Code005
First Use Anywhere DateMonday, August 14, 2023
First Use In Commerce DateMonday, August 14, 2023

Trademark Owner History

Party NameRevance Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressGLENGORMLEY BT365EB
GB
Party NameRevance Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNashville, TN 37203
Party NameRevance Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNashville, TN 37203

Trademark Events

Event DateEvent Description
Friday, August 6, 2021NEW APPLICATION ENTERED
Tuesday, September 28, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 16, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 16, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, November 16, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 16, 2021EXAMINER'S AMENDMENT ENTERED
Wednesday, August 3, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, August 3, 2022SOU EXTENSION 1 GRANTED
Monday, November 15, 2021ASSIGNED TO EXAMINER
Tuesday, November 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, August 3, 2022SOU EXTENSION 1 FILED
Friday, August 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 14, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 14, 2023SOU TEAS EXTENSION RECEIVED
Monday, August 14, 2023SOU EXTENSION 3 FILED
Monday, August 14, 2023SOU EXTENSION 3 GRANTED
Wednesday, February 14, 2024SOU EXTENSION 4 GRANTED
Tuesday, February 14, 2023SOU EXTENSION 2 FILED
Tuesday, February 14, 2023SOU EXTENSION 2 GRANTED
Thursday, February 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 14, 2024SOU EXTENSION 4 FILED
Wednesday, February 14, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, August 13, 2024SOU EXTENSION 5 FILED
Thursday, February 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 13, 2024SOU EXTENSION 5 GRANTED
Wednesday, April 30, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, February 14, 2025USE AMENDMENT FILED
Friday, February 14, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, April 30, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 5, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 5, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 27, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 27, 2025REGISTERED-PRINCIPAL REGISTER
Monday, August 4, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, August 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, August 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, August 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, August 4, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

Related Keywords

therapeutics revance muscle preparations spasms pain pharmaceutical dystonias disorders treatment neurological substrates